US Patent Issued to INTERNATIONAL BUSINESS MACHINES on April 14 for "Antigen-binding proteins targeting coronavirus (COV) variants" (New York Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,764, issued on April 14, was assigned to INTERNATIONAL BUSINESS MACHINES Corp. (Armonk, N.Y.).

"Antigen-binding proteins targeting coronavirus (COV) variants" was invented by Binquan Luan (Chappaqua, N.Y.), Leili Zhang (Yorktown Heights, N.Y.) and Tien Huynh (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Techniques regarding antigen-binding proteins that can bind to CoV (e.g., SARS-CoV-2) variants are provided. For example, one or more embodiments described herein can comprise an antigen-binding protein that can comprise a heavy polypeptide chain variable region with an amino acid sequence that is a variant of SEQ ID NO: 7. ...